Quantifying antiretroviral risk in pregnancy

Rossouw, Theresa M.

dc.contributor.upauthor	Rossouw, Theresa M.
dc.date.accessioned	2008-06-02T13:17:25Z
dc.date.available	2008-06-02T13:17:25Z
dc.date.issued	2007-11
dc.description.abstract	No abstract available	en
dc.format.extent	93955 bytes
dc.format.mimetype	application/pdf
dc.identifier.citation	Rossouw, T 2007, 'Quantifying antiretroviral risk in pregnancy', South African Medical Journal, vol. 97, no. 11, pp. 1014-1015. [www.samj.org.za ]	en
dc.identifier.issn	0038-3469
dc.identifier.uri	http://hdl.handle.net/2263/5754
dc.language.iso	en	en
dc.publisher	Health and Medical Publishing Group	en
dc.rights	Health and Medical Publishing Group	en
dc.subject	Antiretroviral drugs	en
dc.subject	Risk factors	en
dc.subject	Risks	en
dc.subject	Fetal outcome	en
dc.subject	Efavirenz	en
dc.subject	Pregnancy	en
dc.subject	Neural tube defects	en
dc.subject	Birth defects	en
dc.subject	First trimester	en
dc.subject	Highly active antiretroviral therapy (HAART)	en
dc.subject	Viral loads	en
dc.subject	Obstetric outcome	en
dc.subject	Neonatal outcomes	en
dc.subject	Statistics	en
dc.subject	Treatment Outcome	en
dc.subject	Gauteng	en
dc.subject.lcsh	Pregnant women
dc.subject.lcsh	HIV-positive women
dc.subject.lcsh	Antiretroviral agents
dc.subject.lcsh	Fetus--Development
dc.subject.lcsh	Newborn infants
dc.title	Quantifying antiretroviral risk in pregnancy	en
dc.type	Text	en